What we do
Smiths Medical is dedicated to supporting healthcare professionals and providers to enhance patient outcomes and help save lives.
We develop high quality, specialised medical devices and consumables that are found in hospitals, ambulances, homes and specialty care environments.
They are used during critical and intensive care, surgery, post-operative care and for support in managing chronic illnesses.
In hospitals around the world, doctors treat patients with confidence using our trusted medical devices designed to administer the safest and most effective treatment for a range of medical conditions.
A global presence
We sell our products in over 120 countries and have operations in over 30. Smiths Medical’s expertise provide lifesaving solutions for the world’s healthcare markets.
£184m2020 headline operating profit
- Smiths Medical
- Smiths Group
Infusion Systems products deliver medication for treating chronic conditions, in hospital and home settings. Smiths Medical is one of the market leaders in ambulatory infusion and have strong positions in the syringe pump market.
Vascular Access products protect healthcare workers and patients from both needlestick injury and hospital-acquired infection.
Vital Care products help manage patient airways before, during and after surgery.
Customers include hospitals, surgery centres, clinics, home care providers and other medical device manufacturers.
- Ageing populations with increasing personalised healthcare and patient expectation/quality of life
- Increasing incidence of chronic diseases
- Increasing need for connected systems and data analytics
- Growth of alternate site and home based healthcare
- Growing healthcare spend in developing markets
The areas of care we specialise in include general anaesthesia, critical care, oncology, cardiology, respiratory care, alternate care, pain management, veterinary, home care, emergency medicine, neonatal and paediatric critical care and regional anaesthesia.
Our solutions include airway management, interventional imaging, IV catheters, safety devices, vascular access, drainage systems, pain management, pressure monitoring, temperature management, ventilation, infusion, patient monitoring, respiratory and tracheostomy.
Our strategy is to achieve category leadership in the infusion segment and selected vascular access and vital care segments. We will achieve this with commercially focused innovations, differentiation in our customer support model, and delivery of complete solutions that optimise patient outcomes. We will continue to enhance both our own R&D and our external partnerships to execute our strategy in line with healthcare megatrends.
In order to invest in our future, we will continue to improve our efficiency and operational excellence. Part of this investment, besides customer solutions, will include further developing our people.
We will also continue to improve our capabilities in growing markets outside of North America and Western Europe, enhancing our current global footprint and sales reach. In addition, we will continue to pursue channel optimisation and access to care outside of hospitals.
OUTPERFORMING OUR CHOSEN MARKETS
Launched 12 new products in the past year including:
- The CADD®-Solis VIP multi-therapy ambulatory infusion pump
- Acapella® choice vibratory positive expiratory pressure therapy system
- HOTLINE® blood and fluid warmer
DELIVER WORLD-CLASS COMPETITIVENESS
- Continuous improvement and lean manufacturing
- Sales focused on: customer retention and top line growth; implementation of cloud based sales technology; expanding market reach with an increased emphasis on commercial partnerships